AGXT Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of AGXT Antibodies for investigating alanine-glyoxylate aminotransferase (AGXT) in various biological processes. AGXT Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AGXT is a key enzyme involved in the metabolism of glyoxylate and plays a crucial role in the conversion of glyoxylate to glycine. AGXT maintains metabolic balance and prevents the accumulation of toxic metabolites, which can lead to conditions such as primary hyperoxaluria. Research has shown that AGXT dysfunction contributes to various metabolic disorders, making it an important target for therapeutic development. Understanding AGXT's molecular mechanisms and regulatory pathways provides valuable insights into metabolic disease progression. Investigating AGXT expression patterns and interactions helps reveal its role in cellular homeostasis. AGXT research using Santa Cruz Biotechnology monoclonal antibodies advances scientific understanding of metabolic processes and supports the development of new therapeutic strategies.